Search Results

Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial

Authors: YE, B. D.; CHEON, J. H.; CHOI, K. D.; KIM, S. G.; KIM, J. S.; JUNG, H. C.; SONG, I. S.

Source: Alimentary Pharmacology & Therapeutics, Volume 24, Number 5, September 2006 , pp. 837-843(7)

Publisher: Blackwell Publishing

Prevention of the rehaemorrhage of bleeding peptic ulcers: effects of Helicobacter pylori eradication and acid suppression

Authors: Kikkawa, A.; Iwakiri, R.; Ootani, H.; Ootani, A.; Fujise, T.; Sakata, Y.; Amemori, S.; Tsunada, S.; Sakata, H.; Koyama, T.; Fujimoto, K.

Source: Alimentary Pharmacology & Therapeutics, Volume 21, Supplement 2, June 2005 , pp. 79-84(6)

Publisher: Blackwell Publishing

A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration

Authors: Yamaguchi, Y.; Katsumi, N.; Tauchi, M.; Toki, M.; Nakamura, K.; Aoki, K.; Morita, Y.; Miura, M.; Morozumi, K.; Ishida, H.; Takahashi, S.

Source: Alimentary Pharmacology & Therapeutics, Volume 21, Supplement 2, June 2005 , pp. 111-115(5)

Publisher: Blackwell Publishing

Gastrointestinal Disease Control After Histamine₂-Receptor Antagonist Dose Modification for Renal Impairment in Frail Chronically Ill Elderly Patients

Authors: Lackner, Thomas E.; Heard, Tom; Glunz, Samantha; Gann, Nicole; Babington, Maude; Malone, Daniel C.

Source: Journal of the American Geriatrics Society, Volume 51, Number 5, May 2003 , pp. 650-656(7)

Publisher: Blackwell Publishing

Arthritis treatment in Hong Kong — cost analysis of celecoxib versus conventional NSAIDS, with or without gastroprotective agents

Authors: You, J. H. S.; Lee, K. K. C.; Chan, T. Y. K.; Lau, W. H.; Chan, F. K. L.

Source: Alimentary Pharmacology & Therapeutics, Volume 16, Number 12, December 2002 , pp. 2089-2096(8)

Publisher: Blackwell Publishing

The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers

Authors: Miller A.K.; DiCicco R.A.; Freed M.I.

Source: Clinical Therapeutics, Volume 24, Number 7, July 2002 , pp. 1062-1071(10)

Publisher: Elsevier

Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials

Authors: Caro J.J.; Salas M.; Ward A.

Source: Clinical Therapeutics, Volume 23, Number 7, July 2001 , pp. 998-1017(20)

Publisher: Elsevier

What Is Heartburn Worth?: A Cost-Utility Analysis of Management Strategies

Authors: Heudebert, Gustavo R.; Centor, Robert M.; Klapow, Joshua C.; Marks, Robert; Johnson, Lawrence; Wilcox, C. Mel

Source: Journal of General Internal Medicine, Volume 15, Number 3, March 2000 , pp. 175-182(8)

Publisher: Blackwell Publishing

Economic impact of inappropriate histamine₂-receptor antagonist use

Authors: Wadibia E.C.; Lucas B.D.; Hilleman D.E.; Mooss A.N.

Source: Clinical Therapeutics, Volume 19, Number 5, September 1997 , pp. 1085-1091(7)

Publisher: Elsevier

Management of NSAID-induced gastropathy: an economic decision analysis

Authors: Goldstein J.L.; Larson L.R.; Yamashita B.D.; Boyd M.S.

Source: Clinical Therapeutics, Volume 19, Number 6, November 1997 , pp. 1496-1509(14)

Publisher: Elsevier

Administration of a histamine₂-receptor antagonist in reflux esophagitis after gastrectomy: simultaneous pH monitoring of the esophagus and residual stomach

Authors: Yoshida M.; Otani Y.; Ishikawa H.; Igarashi N.; Fujita K.; Hayashi N.; Ishizuka H.; Kubota T.; Kumai K.; Kitajima M.

Source: Current Therapeutic Research, Volume 57, Number 11, November 1996 , pp. 869-877(9)

Publisher: Elsevier

The tolerability and safety profile of famotidine

Authors: Howden C.W.; Tytgat G.N.J.

Source: Clinical Therapeutics, Volume 18, Number 1, January 1996 , pp. 36-54(19)

Publisher: Elsevier

Cost of acid peptic disorders in a managed-care organization

Authors: Segal R.; Russell W.L.; Ben-Joseph R.; Mansheim B.

Source: Clinical Therapeutics, Volume 18, Number 2, March 1996 , pp. 319-333(15)

Publisher: Elsevier

The effectiveness of gastric pH control with bolus famotidine versus cimetidine for stress ulcer prophylaxis in a surgical intensive care unit

Authors: Wang C.-S.; Chen M.-F.; Bullard M.J.; Liao C.-C.

Source: Current Therapeutic Research, Volume 56, Number 5, May 1995 , pp. 530-541(12)

Publisher: Elsevier

Roxatidine versus ranitidine in the short-term management of duodenal ulcer: a randomized, double-blind trial

Authors: Chang F.-Y.; Lee C.-T.; Ng W.-W.; Lee S.-D.; Reuter M.K.

Source: Current Therapeutic Research, Volume 56, Number 10, October 1995 , pp. 1041-1048(8)

Publisher: Elsevier

Are enterochromaffinlike cell tumours reversible? An experimental study on gastric carcinoids induced in Mastomys by histamine₂-receptor blockade

Authors: Wangberg B.; Nilsson O.; Theodorsson E.; Modlin I.M.; Dahlstrom A.; Ahlman H.

Source: Regulatory Peptides, Volume 56, Number 1, 7 March 1995 , pp. 19-33(15)

Publisher: Elsevier